CFDE Data Portal | Search GOLGA7B

	Label	Description
	GOLGA7B Gene (Entity type)	ENSG00000155265 - golgin A7 family member B
	GOLGA7B associations Collection (Entity type)	Associations for GOLGA7B_associations
	GOLGA7B associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GOLGA7B-DT Gene (Entity type)	ENSG00000227356 - GOLGA7B divergent transcript
	GSE193351 ruxolitinib 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE229973 3 V 2 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE187006 3 V 2 VALPROIC ACID HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 7 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 11 V 6 SULFORAPHANE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE145195 PPP2R3B overexpression 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS

GOLGA7B

ENSG00000155265 - golgin A7 family member B

GOLGA7B associations

Associations for GOLGA7B_associations

GOLGA7B associations.tsv

A file from IDG as part of the Harmonizome project

GOLGA7B-DT

ENSG00000227356 - GOLGA7B divergent transcript

GSE193351 ruxolitinib 1 v 2 human dn

A Gene Set from LINCS

GSE229973 3 V 2 CISPLATIN HUMAN DN

A Gene Set from LINCS

GSE187006 3 V 2 VALPROIC ACID HUMAN UP

A Gene Set from LINCS

GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 7 v 5 human dn

A Gene Set from LINCS

GSE48812 11 V 6 SULFORAPHANE HUMAN DN

A Gene Set from LINCS

GSE145195 PPP2R3B overexpression 0 v 1 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.